Results 221 to 230 of about 422,827 (356)
A Survival Epidemiology Framework for Oral and Oropharyngeal Cancer
ABSTRACT Oral and oropharyngeal cancer remains a major global public health burden, but the literature addressing this disease is still organized predominantly around who develops it rather than around what determines life after diagnosis. That imbalance is consequential because diagnosis initiates a new scientific problem.
Raphael E. Cuomo
wiley +1 more source
Healthcare costs in patients with head and neck cancer. [PDF]
Smith J +3 more
europepmc +1 more source
ABSTRACT Aim Persistent high‐risk HPV infection can lead to the development of precancerous lesions, potentially progressing to invasive cancer. HPV status serves not only as a prognostic marker for squamous cell carcinoma (HNSCC) like oropharyngeal squamous cell carcinomas (OPSCC) but also significantly influences clinical management and treatment ...
Min Wang +9 more
wiley +1 more source
Out-of-Pocket Costs and Antidepressant Adherence in Head and Neck Cancer Survivors. [PDF]
Tosto GD +4 more
europepmc +1 more source
Despite developments in supporting the identification and selection of fit‐for‐purpose registries, a translational gap remains between the original purposes of clinically focused registries and their current and future expected use in policymaking. This study aimed to assess the extent to which cancer‐focused registries collect essential data elements ...
Manon C. Wilpshaar +4 more
wiley +1 more source
HPV genotyping in head and neck cancer: Insights from a Colombian cohort. [PDF]
Cruz-Romero SD +7 more
europepmc +1 more source
ABSTRACT Cell‐in‐cell (CIC) structures are among the most intriguing cellular phenomena occasionally observed in human cancer specimens. Once regarded as incidental findings, accumulating evidence has linked specific CIC subtypes, particularly entosis, to tumor progression and patient prognosis.
Maria V. Leyba‐Mesa +4 more
wiley +1 more source
Xenobiotic Sulforaphane in Head and Neck Cancer: Beyond the Nrf2 Pathway. [PDF]
Polizzi A +10 more
europepmc +1 more source
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
M. Posner, D. Hershock, C. Blajman
semanticscholar +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source

